PRELIMINARY SCIENTIFIC PROGRAM As of 29 January 2018 Plenary session Parallel Session Break Industry Session Oral Presentation Session Ask the speaker feature in App Voting feature in App Wednesday, 14 February 2018 B L3 M N 14:30-16:00 16:00 16:15 16:15-17:45 17:45 18:00 SYMPOSIUM SHORT BREAK TO CHANGE S SHORT BREAK TO CHANGE S A SYMPOSIUM 18:00-19:00 OPENING CEREMONY Moshe Phillip - Opening Remarks Thomas Danne Beyond A1c: Consensus on CGM Outcomes 19:00-20:00 NETWORKING RECEPTION (In the Exhibition Area)
Thursday, 15 February 2018 08:00-09:30 09:30-10:00 10:00-10:30 10:30-12:00 A PLENARY SESSION COPING WITH GLUCOSE VARIABILITY Stephanie Amiel Reversibility of Brain Changes in Diabetes Satish Garg - Role of Concentrated Insulins in Diabetes Care Bruce Bode - Review of Ultra-Rapid Acting Insulins Jennifer Sherr - Nasal Glucagon: an alternative innovative needle free approach for the treatment of severe hypoglycemia COFFEE BREAK, EXHIBITION, POSTERS AND E- POSTERS DISCUSSIONS 1-3 E-POSTER DISCUSSION 1 AT STATION 2 E-POSTER DISCUSSION 2 AT STATION 4 E-POSTER DISCUSSION 3 AT STATION 6 12:00- LUNCH BREAK, EXHIBITION, E- POSTERS AND POSTERS, INTERNATIONAL FAIR OF NEW TECHNOLOGIES IN DIABETES 13:00 B C L3 M N 13:00-14:30 GLUCOSE METRICX: BEYOND HbA1c SYMPOSIUM Industry session not included in main event CME/CPD credit WORKSHOP Industry session not included in main event CME/CPD credit PRESENTATIONS OF START-UP COMPANIES NEXT GENERATION SOLUTIONS Irl Hirsch - Time in Ranges or HbA1c? Richard Bergenstal - Glucose Variability: Which Measures Are Clinically Meaningful? Hans DeVries - Glycation Gap: Does It Exist? Join this session to meet the start-up finalists and unpack their ideas. Judged by ATTD s expert panel as the most exciting innovations from the largest number of entries we have ever had, this session is a must for the investor community and those David Klonoff - Trends in Digital Health for Diabetes Francis Doyle III - Dealing with Patient and Device Uncertainty in the Artificial Pancreas: Multi-zones, Adaptation, and Trust Indices Eyal Dassau Next Generation Automated Insulin Delivery: On-
Simon Heller - Hypoglycemia and Mortality: A Causal Relationship? with an eye out for the next big thing. COFFEE BREAK, EXHIBITION, E- POSTERS AND POSTERS, INTERNATIONAL FAIR OF NEW TECHNOLOGIES IN DIABETES A Body Ecosystem for Automated Insulin Delivery in Type 1 Diabetes Neal Kaufman - Digital Self- Management Support Interventions: Foundational to Improving Health Outcomes 14:30-15:00 15:00-16:30 16:30- SHORT BREAK TO CHANGE S 16:40 B C L3 M N 16:40-18:00 ACCESS TO NOVEL TECHNOLOGY DEBATE: PUMP V. SENSOR WHAT IS MORE IMPORTANT? IT IS NOT JUST ABOUT GLUCOSE ORAL PRESENTATION SESSION 1 ORAL PRESENTATION SESSION 2 Irl Hirsch - Cost of Medications Vs. Outcomes: Is there an End George Grunberger We Have the Technology, We Have the Data, and Now What? Aaron Kowalski - The Role of Patients in Increasing Access to New Treatments Henk J. Veeze - Value Based Health Care / Diabeter Experience Lalantha Leelarathna Pumps Hans DeVries Sensors Discussion Lori Laffel Aligning Patient Expectations with Automated Insulin Delivery System: Understanding Patients Reported Outcomes Katharine Barnard Supporting Healthcare Professionals: Finding the QoL Balance Pratik Choudhary Understanding the Relationship Between Diabetes Distress and Metabolic Outcomes
Friday, 16 February 2018 B 09:00-10:00 CLOSING THE LOOP - NIH-FUNDED AP RESEARCH EFFORTS PARALLEL SESSION: BIOTECHNOLOGY AND DIABETES WORKSHOP Industry session not included in main event CME/CPD credit PRESENTATIONS OF START-UP COMPANIES ORAL PRESENTATION SESSION 3 MOVING FORWARD WITH REGULATORY APPROVAL 08:00-08:50 PLENARY INDUSTRY MORNING SYMPOSIUM 08:50- SHORT BREAK TO CHANGE S 09:00 B C L3 L6 M N 10:00-10:30 Boris Kovatchev - The International Diabetes Closed-Loop (idcl) Trial Roman Hovorka - Day and Night Closed-loop in Young People with Type 1 Diabetes (DAN05) Richard Bergenstal - A Crossover Study Comparing Two Automated Insulin Delivery System Algorithms in Adolescents and Young Adults with Type 1 Diabetes Steven Russell - Bionic Pancreas Treats Adults with Type 1 Diabetes Desmond Schatz Update on Worldwide Efforts to Prevent Type 1 Diabetes Mark Sperling: Post-transplant Diabetes in Children and Adolescents Lorenzo Piemonti - Beta Cell Replacement, Where Are We? COFFEE BREAK, EXHIBITION, POSTERS AND E- POSTERS DISCUSSIONS 4-6 E-POSTER DISCUSSION 4 AT STATION 2 E-POSTER DISCUSSION 5 AT STATION 4 E-POSTER DISCUSSION 6 AT STATION 6 09:00-09:30 Stayce Beck FDA Perspectives on Advances in CGM Technologies SYMPOSIUM 09:40-10:00
A 10:30-12:00 12:00-13:00 13:00-14:30 LUNCH BREAK, EXHIBITION, E- POSTERS AND POSTERS, INTERNATIONAL FAIR OF NEW TECHNOLOGIES IN DIABETES PLENARY SESSION ATTD YEARBOOK B Irl B. Hirsch -Self-monitoring of Blood Glucose Bruce Bode - Continuous Glucose Monitoring John Pickup - Insulin Pumps Eyal Dassau - Closing the Loop Thomas Danne - New Insulins, biosimilars, and Insulin Therapy Neal Kaufman - Using Digital Health Technology to Prevent and Treat Diabetes Desmond Schatz - Immune Intervention for type 1 diabetes Helen Murphy - Technology and Pregnancy Michael C. Riddell - Advances in Exercise Physical Activity and Diabetes Mellitus, David Maahs - Diabetes Technology and Therapy in the Pediatric Age Group Alon Liberman - Diabetes Technology and the Human Factor Satish Garg - New Medications for the Treatment of Diabetes 14:30-15:00 15:00-16:30 16:30-16:40 COFFEE BREAK, EXHIBITION, E- POSTERS AND POSTERS, INTERNATIONAL FAIR OF NEW TECHNOLOGIES IN DIABETES SHORT BREAK TO CHANGE S A
B C L3 L6 M N 16:40-18:00 PARALLEL SESSION: CLINICAL DECISION SUPPORT SYSTEMS (ADVISORS) ISPAD SESSION CENGES WITH DIABETES TECHNOLOGY IN PEDIATRICS NUTRITION AND FOOD TECHNOLOGIES WORKSHOP Industry session not included in main event CME/CPD credit SYMPOSIUM Industry session not included in main event CME/CPD credit MAJOR OUTCOME STUDIES: THE HypoDE STUDY Deborah Mullen Using Glucose Profiles (AGP) for Shared Decision Making Mark Clements Machine Learning to Improve T1D Care Revital Nimri - Automated Decision Support System for Medical Team Who Treats Patients with Type 1 Diabetes Boris Kovatchev - Decision Support Systems Ragnar Hanas - Diabetes Technology in the <6-yearold Population Laurel Messer - Practical Issues in School with Diabetes Technology Eda Cengiz - Diabetes Technology in Adolescents and Young Adults Eduardo Calliari - Diabetes Technology in Developing Countries Michal Gillon Keren Introduction Eran Segal - Personalized Medicine Approaches for Treatment of Diabetes Based on Gut Microbiota Stavroula Mougiakakou - The future role of machine learning and computer vision in carbohydrate estimation for diabetic patients Andrea Scaramuzza - Efficacy of an APP to Count Carbs and Beyond to Limit the Postmeal Glucose Rise in Children with Type 1 Diabetes Guido Freckmann - Study Design and Execution Lutz Heinemann - Results Norbert Hermanns - Patient Related Outcomes Hans DeVries - Independent Commentary
Saturday, 17 February 2018 B C L3 M N 08:30-10:00 DEBATE: CAN DIGITAL HEALTH REPLACE THE HCP? DIABETES TECHNOLOGY FOR TYPE 2 DIABETES DIABETES INDIA SYMPOSIUM ORAL PRESENTATION SESSION 5 ORAL PRESENTATION SESSION 4 Revital Nimri Pro Lori Laffel con Discussion Yves Reznik - Insulin Pump and CGM Eric Renard - Artificial Pancreas Marc Breton - Decision Tools S. R. Aravind - Evolution of Technologies in India Manoj Chawla - Use of Insulin Pump Therapy in India - The Changing Perspective Jothydev Kesavadev - SMBG and Virtual Consultation DTMS (R): 20 Years' Experience Banshi Saboo - CGM & AGP - How to Reap Its Benefit From Busy Clinics in India? 10:00- COFFEE BREAK, EXHIBITION, E- POSTERS AND POSTERS, INTERNATIONAL FAIR OF NEW TECHNOLOGIES IN DIABETES 10:30 B C L3 M 10:30-12:00 PUMPS, SENSORS & FGM WHERE DO WE GO? TURKISH DIABETES TECHNOLOGY GROUP: GLYCEMIC VARIATION IN DIABETES CONTROL PRACTICAL CLOSED LOOP THERAPY: EDUCATION AND IMPLEMENTATION ORAL PRESENTATION SESSION 6 John Pickup - What Determines the Effectiveness of Insulin Pump Therapy: Towards Precision Diabetes Technology? Jan Bolinder - Review of Flash Glucose Monitoring Benefits vs Capillary and vs CGM Damla Göksen - Glycemic Variability vs Glucose Control in Children Selçuk Dağdelen - Glycemic Variability vs Glucose Control in Adults Laurel Messer - Artificial Pancreas: Managing Expectations, Misconceptions and Preparing Patients for Success Sarah Biester- Train the Trainer: What do Clinicians Need to Understand About CL Technology?
Nebojsa Lalic - Insulin Pump Treatment in Type 2 Diabetes: Impact on Insulin Resistance and Related Metabolic Parameters Riccardo Bonfanti - CGM Standalone in Children Using Multiple Daily Injections Eda Cengiz - New Short and Long Acting Insulin Analogues and Glycemic Variability L3 Jennifer Sherr - Patients Perspective on Closed- loop Technology Barbara Murn Berkopec - Addressing Barriers to CGM and CL Therapies 12:00-13:00 13:00-13:05 13:05-13:45 PLENARY SESSION SURGICAL AND PHARMACEUTICAL SOLUTIONS FOR OBESE PEOPLE WITH TYPE 2 DIABETES Francesco Rubino - Insulin-independent Mechanisms of Action of Bariatric/Metabolic Surgery Walter Pories The Downside to Metabolic (bariatric) Surgery Timo Müller Novel Pharmacological Approaches to Treat Obesity and T2 Diabetes CLOSING REMARKS AND FAREWELL Tadej Battelino FAREWELL REFRESHMENTS (In the Exhibition Area)